NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) income statement
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3081% below fair value
$0.65−0.02 (-3.38%)
Close on Nov 20, 2026Market cap $5.94MP/E –Yield –
NEUROONE MEDICAL TECHNOLOGIES Corp financial ratios
See a number that looks wrong?